Research AI

Scans

Tools

Watchlists

Home

Charts

Watchlist

Products

EP Biocomposites Ltd

EPBIO·BSE

₹100.000.00%Fri, 18 Sept '26

Industry:Miscellaneous

Indices:

EP Biocomposites Ltd

EPBIO

BSE

₹100.00

0.00%

|Fri, 18 Sept '26

SOICxStockScans Reports

Industry

Miscellaneous

Indices

View

Financials

Documents

Shareholdings

Corporate Actions

Segments

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Financials

Documents

Shareholdings

Corporate Actions

Segments

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Quick Ratios

Edit Ratios

Mkt Cap

Market Capitalization

₹17Cr

Close Price

₹100.00

Industry

Miscellaneous

Price To Earnings

11.53

Price To Sales

1.23

Revenue

₹14Cr

Rev Gr TTM

Revenue Growth TTM

13.67%

PAT Gr TTM

PAT Growth TTM

40.38%

Quarterly Results

Standalone

Numbers

Percentage

Quarter	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Revenue RevenueCr	3	5	3	4	4	7	4	8	4	10
Growth YoY Revenue Growth YoY%			25.0	-30.6	27.5	91.3	0.0	8.0	-7.5	25.9
Expenses ExpensesCr	2	4	3	3	4	6	4	6	4	8
Operating Profit Operating ProfitCr	0	1	1	0	0	1	0	1	0	2
OPM OPM%	12.3	19.3	15.4	11.4	6.1	16.2	10.9	17.0	5.9	20.9
Other Income Other IncomeCr	0	0	0	0	0	0	0	0	0	0
Interest Expense Interest ExpenseCr	0	0	0	0	0	0	0	0	0	0
Depreciation DepreciationCr	0	0	0	0	0	0	0	0	0	0
PBT PBTCr	0	1	0	1	0	1	0	1	0	2
Tax TaxCr	0	0	0	0	0	0	0	0	0	0
PAT PATCr	0	1	0	0	0	1	0	1	0	1
Growth YoY PAT Growth YoY%			12.5	-47.4	-18.5	210.0	-4.5	-10.8	-57.1	65.1
NPM NPM%	8.7	10.8	7.8	8.2	5.0	13.2	4.8	10.9	2.2	14.3
EPS EPS₹	0.0	0.0	2.2	1.8	1.3	4.2	1.2	4.9	0.5	8.1

Quarter	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Revenue RevenueCr	3	5	3	4	4	7	4	8	4	10
Growth YoY Revenue Growth YoY%			25.0	-30.6	27.5	91.3	0.0	8.0	-7.5	25.9
Expenses ExpensesCr	2	4	3	3	4	6	4	6	4	8
Operating Profit Operating ProfitCr	0	1	1	0	0	1	0	1	0	2
OPM OPM%	12.3	19.3	15.4	11.4	6.1	16.2	10.9	17.0	5.9	20.9
Other Income Other IncomeCr	0	0	0	0	0	0	0	0	0	0
Interest Expense Interest ExpenseCr	0	0	0	0	0	0	0	0	0	0
Depreciation DepreciationCr	0	0	0	0	0	0	0	0	0	0
PBT PBTCr	0	1	0	1	0	1	0	1	0	2
Tax TaxCr	0	0	0	0	0	0	0	0	0	0
PAT PATCr	0	1	0	0	0	1	0	1	0	1
Growth YoY PAT Growth YoY%			12.5	-47.4	-18.5	210.0	-4.5	-10.8	-57.1	65.1
NPM NPM%	8.7	10.8	7.8	8.2	5.0	13.2	4.8	10.9	2.2	14.3
EPS EPS₹	0.0	0.0	2.2	1.8	1.3	4.2	1.2	4.9	0.5	8.1

Profit & Loss

Standalone

Numbers

Percentage

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue RevenueCr	1	3	8	7	11	12	14
Growth Revenue Growth%		418.9	173.4	-11.5	60.4	5.0	13.6
Expenses ExpensesCr	1	2	7	6	10	10	11
Operating Profit Operating ProfitCr	0	0	1	1	1	2	2
OPM OPM%	7.6	15.6	17.0	13.3	12.3	14.8	16.4
Other Income Other IncomeCr	0	0	0	0	0	0
Interest Expense Interest ExpenseCr	0	0	0	0	0	0	0
Depreciation DepreciationCr	0	0	0	0	0	0	0
PBT PBTCr	0	0	1	1	2	1	2
Tax TaxCr	0	0	0	0	0	0	0
PAT PATCr	0	0	1	1	1	1	1
Growth PAT Growth%		1,032.9	126.1	-28.8	99.6	-10.3	41.6
NPM NPM%	5.6	12.1	10.0	8.1	10.1	8.6	10.7
EPS EPS₹	0.6	7.0	9.5	3.9	6.8	6.1	8.7

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue RevenueCr	1	3	8	7	11	12	14
Growth Revenue Growth%		418.9	173.4	-11.5	60.4	5.0	13.6
Expenses ExpensesCr	1	2	7	6	10	10	11
Operating Profit Operating ProfitCr	0	0	1	1	1	2	2
OPM OPM%	7.6	15.6	17.0	13.3	12.3	14.8	16.4
Other Income Other IncomeCr	0	0	0	0	0	0
Interest Expense Interest ExpenseCr	0	0	0	0	0	0	0
Depreciation DepreciationCr	0	0	0	0	0	0	0
PBT PBTCr	0	0	1	1	2	1	2
Tax TaxCr	0	0	0	0	0	0	0
PAT PATCr	0	0	1	1	1	1	1
Growth PAT Growth%		1,032.9	126.1	-28.8	99.6	-10.3	41.6
NPM NPM%	5.6	12.1	10.0	8.1	10.1	8.6	10.7
EPS EPS₹	0.6	7.0	9.5	3.9	6.8	6.1	8.7

Balance Sheet

Standalone

Numbers

Percentage

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital Equity CapitalCr	0	0	1	2	2	2
Reserves ReservesCr	0	0	1	7	8	9
Current Liabilities Current LiabilitiesCr	1	1	5	2	4	4
Non Current Liabilities Non Current LiabilitiesCr	0	0	2	1	1	2
Total Liabilities Total LiabilitiesCr	1	1	9	12	15	17
Current Assets Current AssetsCr	1	1	9	9	12	14
Non Current Assets Non Current AssetsCr	0	0	1	2	3	3
Total Assets Total AssetsCr	1	1	9	12	15	17

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital Equity CapitalCr	0	0	1	2	2	2
Reserves ReservesCr	0	0	1	7	8	9
Current Liabilities Current LiabilitiesCr	1	1	5	2	4	4
Non Current Liabilities Non Current LiabilitiesCr	0	0	2	1	1	2
Total Liabilities Total LiabilitiesCr	1	1	9	12	15	17
Current Assets Current AssetsCr	1	1	9	9	12	14
Non Current Assets Non Current AssetsCr	0	0	1	2	3	3
Total Assets Total AssetsCr	1	1	9	12	15	17

Cash Flow

Standalone

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	0	0	-4	-1	-1	0	2
Investing Cash Flow Investing Cash FlowCr	0	0	0	0	0	0	-1
Financing Cash Flow Financing Cash FlowCr	0	0	5	3	0	1	-1
Net Cash Flow Net Cash FlowCr	0	0	0	2	-1	0	1
Free Cash Flow Free Cash FlowCr	0	0	-5	-1	-1	-1	2
CFO To PAT CFO To PAT%	367.7	9.3	-528.8	-137.8	-108.2	-47.5	136.3
CFO To EBITDA CFO To EBITDA%	270.2	7.2	-311.9	-83.6	-88.4	-27.6	88.8

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	0	0	-4	-1	-1	0	2
Investing Cash Flow Investing Cash FlowCr	0	0	0	0	0	0	-1
Financing Cash Flow Financing Cash FlowCr	0	0	5	3	0	1	-1
Net Cash Flow Net Cash FlowCr	0	0	0	2	-1	0	1
Free Cash Flow Free Cash FlowCr	0	0	-5	-1	-1	-1	2
CFO To PAT CFO To PAT%	367.7	9.3	-528.8	-137.8	-108.2	-47.5	136.3
CFO To EBITDA CFO To EBITDA%	270.2	7.2	-311.9	-83.6	-88.4	-27.6	88.8

Ratios

Standalone

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr				34	23	21	14	17
Price To Earnings Price To Earnings				58.8	20.1	20.1	9.7	11.5
Price To Sales Price To Sales				4.8	2.0	1.7	1.0	1.2
Price To Book Price To Book				4.0	2.4	2.0	1.2	1.4
EV To EBITDA EV To EBITDA				34.7	16.8	12.4		7.6
Profitability Ratios Profitability Ratios
GPM GPM%	15.6	38.3	38.4	42.2	34.3	35.5
OPM OPM%	7.6	15.6	17.0	13.3	12.3	14.8	16.4	16.4
NPM NPM%	5.6	12.1	10.0	8.1	10.1	8.6	10.7	10.7
ROCE ROCE%	138.9	120.1	21.6	10.5	14.1	13.1
ROE ROE%	110.5	92.6	40.5	6.8	12.0	9.7
ROA ROA%	5.7	27.0	8.7	4.9	7.6	6.2
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr				34	23	21	14	17
Price To Earnings Price To Earnings				58.8	20.1	20.1	9.7	11.5
Price To Sales Price To Sales				4.8	2.0	1.7	1.0	1.2
Price To Book Price To Book				4.0	2.4	2.0	1.2	1.4
EV To EBITDA EV To EBITDA				34.7	16.8	12.4		7.6
Profitability Ratios Profitability Ratios
GPM GPM%	15.6	38.3	38.4	42.2	34.3	35.5
OPM OPM%	7.6	15.6	17.0	13.3	12.3	14.8	16.4	16.4
NPM NPM%	5.6	12.1	10.0	8.1	10.1	8.6	10.7	10.7
ROCE ROCE%	138.9	120.1	21.6	10.5	14.1	13.1
ROE ROE%	110.5	92.6	40.5	6.8	12.0	9.7
ROA ROA%	5.7	27.0	8.7	4.9	7.6	6.2
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Documents — EP Biocomposites Ltd

Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/7conq92m7n98m2wgkukzsfzx.pdf
Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/45dya0s794tiqqfd9ypt598f.pdf
Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/d6s8sh9tfr18kahxhobmkveh.pdf
Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/xqwnt729tuvozdarr921ihal.pdf
Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/bwcubm5wlj8ad1ooj8jlcokp.pdf
Q2 FY2024 Quarterly Result (Sep 2023, PDF): https://www.stockscans.in/document/8f1lk7c7poys3hmdjterm4vv.pdf
FY2026 Annual Report (PDF): https://www.stockscans.in/document/zxg0smw8sm16da9xyzeo7iwr.pdf
FY2025 Annual Report (PDF): https://www.stockscans.in/document/s358ylbned3fl3tmxn74fkpl.pdf
FY2024 Annual Report (PDF): https://www.stockscans.in/document/lyahgbz7z8jjab650gntqimi.pdf
FY2023 Annual Report (PDF): https://www.stockscans.in/document/twtb6ci7x1ou6zix86nobxxi.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in

349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies